Cargando…

A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1

BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Wei, Li, Yong, Hovgaard, Lars, Li, Song, Dai, Wenbin, Wang, Jiancheng, Zhang, Xuan, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446861/
https://www.ncbi.nlm.nih.gov/pubmed/23028226
http://dx.doi.org/10.2147/IJN.S30013
_version_ 1782244026605371392
author Qu, Wei
Li, Yong
Hovgaard, Lars
Li, Song
Dai, Wenbin
Wang, Jiancheng
Zhang, Xuan
Zhang, Qiang
author_facet Qu, Wei
Li, Yong
Hovgaard, Lars
Li, Song
Dai, Wenbin
Wang, Jiancheng
Zhang, Xuan
Zhang, Qiang
author_sort Qu, Wei
collection PubMed
description BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is a large challenge. Here we developed a novel silica-based pH-sensitive nanomatrix of GLP-1 (SPN-GLP-1) in order to provide a strategy for oral peptide delivery. METHODS: SPN-GLP-1 composed of silica nanoparticles and pH-sensitive Eudragit(®) was prepared and characterized by dynamic light scattering, scanning electron microscope, transmission electron microscope, high-performance liquid chromatography, surface analysis, drug release, and so on. Its permeability across the Caco-2 cell monolayer and intestinal mucosa, proteolytic stability against the intestinal enzymes, pharmacokinetics, hypoglycemic effect in the intraperitoneal glucose tolerance test (IPGTT), and primary toxicity were then evaluated. RESULTS: It was indicated that the nanomatrix system obtained had a unique nanoscale structure and pH-sensitivity in drug release. It displayed a five-fold intestinal mucosa permeability and significantly higher proteolytic stability compared to native GLP-1 (P < 0.001). A longer half-life was observed after oral administration of SPN-GLP-1, and its relative bioavailability was 35.67% in comparison to intraperitoneal GLP-1. Oral delivery of SPN-GLP-1 significantly reduced the blood glucose level and its hypoglycemic effect over intraperitoneal GLP-1 reached 77%. There was no evident toxicity of SPN-GLP-1 found from both animal status and histochemical analysis of gastrointestinal tissues. CONCLUSION: The silica-based pH-sensitive nanomatrix designed and prepared here might be considered as a potential oral delivery system not only for GLP-1, but also for other peptide or macromolecular drugs.
format Online
Article
Text
id pubmed-3446861
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34468612012-10-01 A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 Qu, Wei Li, Yong Hovgaard, Lars Li, Song Dai, Wenbin Wang, Jiancheng Zhang, Xuan Zhang, Qiang Int J Nanomedicine Original Research BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is a large challenge. Here we developed a novel silica-based pH-sensitive nanomatrix of GLP-1 (SPN-GLP-1) in order to provide a strategy for oral peptide delivery. METHODS: SPN-GLP-1 composed of silica nanoparticles and pH-sensitive Eudragit(®) was prepared and characterized by dynamic light scattering, scanning electron microscope, transmission electron microscope, high-performance liquid chromatography, surface analysis, drug release, and so on. Its permeability across the Caco-2 cell monolayer and intestinal mucosa, proteolytic stability against the intestinal enzymes, pharmacokinetics, hypoglycemic effect in the intraperitoneal glucose tolerance test (IPGTT), and primary toxicity were then evaluated. RESULTS: It was indicated that the nanomatrix system obtained had a unique nanoscale structure and pH-sensitivity in drug release. It displayed a five-fold intestinal mucosa permeability and significantly higher proteolytic stability compared to native GLP-1 (P < 0.001). A longer half-life was observed after oral administration of SPN-GLP-1, and its relative bioavailability was 35.67% in comparison to intraperitoneal GLP-1. Oral delivery of SPN-GLP-1 significantly reduced the blood glucose level and its hypoglycemic effect over intraperitoneal GLP-1 reached 77%. There was no evident toxicity of SPN-GLP-1 found from both animal status and histochemical analysis of gastrointestinal tissues. CONCLUSION: The silica-based pH-sensitive nanomatrix designed and prepared here might be considered as a potential oral delivery system not only for GLP-1, but also for other peptide or macromolecular drugs. Dove Medical Press 2012 2012-09-14 /pmc/articles/PMC3446861/ /pubmed/23028226 http://dx.doi.org/10.2147/IJN.S30013 Text en © 2012 Qu et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Qu, Wei
Li, Yong
Hovgaard, Lars
Li, Song
Dai, Wenbin
Wang, Jiancheng
Zhang, Xuan
Zhang, Qiang
A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title_full A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title_fullStr A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title_full_unstemmed A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title_short A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
title_sort silica-based ph-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446861/
https://www.ncbi.nlm.nih.gov/pubmed/23028226
http://dx.doi.org/10.2147/IJN.S30013
work_keys_str_mv AT quwei asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT liyong asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT hovgaardlars asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT lisong asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT daiwenbin asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT wangjiancheng asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT zhangxuan asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT zhangqiang asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT quwei silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT liyong silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT hovgaardlars silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT lisong silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT daiwenbin silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT wangjiancheng silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT zhangxuan silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1
AT zhangqiang silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1